It is a classical Israeli miracle.
The Israeli biotech company Accelerated Evolution Biotechnologies (AEBi) has announced a medical breakthrough to cure cancer.
Scientists at AEB say they discovered ways to use peptides, the amino acid chain, to target and kill cancer cells.
SEE ALSO:Why the TB diagnosis could be lung cancer
"We believe we will offer a complete cancer drug for a year," AEBi Chairman Dan Aridor told the Jerusalem Post.
Although the miracle drug is only tested on mice, Israelis are at the forefront of the development of human anti-cancer drugs "in a short time".
Scientists in the company still have years of testing before the drug is approved for medication.
AEBi Chairman of the Board Dan Aridor said, "Our cancer drug will be effective from the first day, it will take several weeks and will not have any or minimum side effects at a much lower price than most treatments on the market."
He continued: "Our solution will be both generic and personal."
SEE ALSO:Over 1000 Black Whitening Products
The first research experiments on mice yielded promising results with indications that inhibited cancer cell growth in humans and had no effect on healthy mice cells.
The next phase of the trial will include clinical trials that could be completed within a few years and provide treatment in specific cases.
In Kenya, the Ministry of Health estimates that about 39,000 new cancer cases are diagnosed every year.
Approximately 27,000 people die each year of this disease, making it the third most common killer disease in the country.
Most likely cancer treatment in Kenya costs Sh500,000, but this figure can also reach millions of shillings when blood cancer is involved.
SEE ALSO:A woman's big fight to beat AIDS and cancer
Accelerated Evolution BiotechnologiesCancerCancer Cure